Organization
Humanitas Research Hospital
4 abstracts
Abstract
Efficacy and safety results from the COMMANDS trial: A phase 3 study evaluating luspatercept vs epoetin alfa in erythropoiesis-stimulating agent (ESA)‑naive transfusion-dependent (TD) patients (pts) with lower‑risk myelodysplastic syndromes (LR-MDS).Org: University of Texas M.D. Anderson Cancer Center, Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, University of Florence, AOUC, Yale School of Medicine and Yale Cancer Center, Yale University, Monash University and Monash Health,
Abstract
Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis.Org: Università degli Studi di Genova and IRCCS Ospedale Policlinico San Martino, San Martino, Italy, Humanitas Research Hospital, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Université Libre de Bruxelles,
Abstract
Circulating tumor DNA of classical Hodgkin lymphoma.Org: Institute of Oncology Research, Aou Federico II, AO S.Croce e Carle, Clinical and Experimental Onco Hematology Unit, Medical University of Gdansk,
Abstract
Profile of toxicities and quality of life in long-term survivors treated with immunotherapy: A prospective cross sectional trial.Org: University of Brescia, ASST Spedali Civili - Brescia, University Hospital of Parma, University of Pisa, Pisa, Italy, ATC Innovation Lab,